Using stem cell-derived vesicles to treat eye injuries from mustard gas exposure
Extracellular Vesicles derived from Mesenchymal Stem Cells as an Effective Medical Countermeasure against Mustard Induced Ocular Injury
This study is looking at a new treatment using tiny particles from special stem cells to help heal eye injuries caused by mustard gas, which could help reduce inflammation and protect your vision if you've been affected by this type of injury.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University Health Science Ctr NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-10863898 on NIH RePORTER |
What this research studies
This research investigates the use of extracellular vesicles derived from mesenchymal stem cells to treat eye injuries caused by mustard gas. The approach focuses on delivering therapeutic proteins and microRNAs that can reduce inflammation and cell death in the eyes, potentially preventing long-term vision loss. By targeting the underlying mechanisms of mustard gas keratopathy, the study aims to develop a novel treatment that could improve healing and restore vision. Patients with chronic eye injuries from mustard gas exposure may benefit from this innovative therapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced ocular injuries from mustard gas and are suffering from chronic conditions like mustard gas keratopathy.
Not a fit: Patients without a history of mustard gas exposure or those with other unrelated ocular conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new treatment option for patients suffering from vision impairment due to mustard gas exposure.
How similar studies have performed: Previous research has shown promise in using stem cell-derived therapies for ocular injuries, indicating that this approach may be effective.
Where this research is happening
College Station, United States
- Texas A&m University Health Science Ctr — College Station, United States (Active)
Researchers
- Principal investigator: Lee, Ryang Hwa — Texas A&m University Health Science Ctr
- Study coordinator: Lee, Ryang Hwa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.